Laryngectomy: Difference between revisions

From Libre Pathology
Jump to navigation Jump to search
Michael (talk | contribs)
→Protocol: create
Michael (talk | contribs)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Laryngectomy''', formally '''total laryngectomy''', is the surgical removal of the [[larynx]].
'''Laryngectomy''' is the surgical removal of the [[larynx]].


==Introduction==
==Introduction==
The usual indication is [[laryngeal cancer]].
The usual indication is high stage [[laryngeal cancer]].<ref name=pmid31136370>{{cite journal |authors=Bates JE, Amdur RJ, Morris CM, Hitchcock KE, Dziegielewski PT, Boyce BJ, Silver NL, Shaw C, Mendenhall WM |title=Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database |journal=Am J Clin Oncol |volume=42 |issue=6 |pages=527–533 |date=June 2019 |pmid=31136370 |doi=10.1097/COC.0000000000000550 |url=}}</ref>


==Specimen opening==
==Specimen opening==
==Protocol==
==Protocol==
The specimen consists of [total larynx/laryngopharyngectomy]
The specimen is a: [total larynx/laryngopharyngectomy].


Components
Components:
*Pharyngeal tissue (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted].
*Pharyngeal tissue (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted].
*Laryngectomy (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted].
*Laryngectomy (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted].
*Thyroid gland [total/partial]: (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted]; appearance [including parenchyma].
*Thyroid gland [total/partial [left/right]]: (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted]; appearance [including parenchyma].
*Tracheal stoma: [describe/not present].
*Tracheal stoma: [describe/not present].



Latest revision as of 14:44, 13 November 2020

Laryngectomy is the surgical removal of the larynx.

Introduction

The usual indication is high stage laryngeal cancer.[1]

Specimen opening

Protocol

The specimen is a: [total larynx/laryngopharyngectomy].

Components:

  • Pharyngeal tissue (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted].
  • Laryngectomy (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted].
  • Thyroid gland [total/partial [left/right]]: (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm; integrity: [intact/disrupted]; appearance [including parenchyma].
  • Tracheal stoma: [describe/not present].

Tumour:

  • Location: [oropharynx,nasopharynx,hypopharynx,state laterality, supraglottis, glottis, transglottis].
  • Dimensions (superior-inferior, left-to-right, anterior-posterior): ___ x ___ x ___ cm.
  • Appearance: [polypoid,exophytic,endophytic,multifocal].
  • Extent of invasion: [epiglottis,aryepiglottic fold,arytenoid,trachea,vocal cords,other stuctures].

Soft Tissue margins:

  • Distal (trachea): ___ cm.
  • Proximal (epiglottic): ___ cm.
  • Anterior: ___ cm.
  • Posterior: ___ cm.
  • Left lateral: ___ cm.
  • Right lateral: ___ cm.
  • Other: ___ cm.

Mucosal margins:

  • Anterior: ___ cm.
  • Posterior: ___ cm.
  • Lateral: ___ cm.
  • Deep: ___ cm.

Neck dissection: [dimensions, bilateral, radical, modified, selective] Lymph nodes: [dimensions, describe].

Representative sections are submitted as follows: [blocks].

Protocol notes

Staging

Alternate approaches

See also

Related protocols

References

  1. ↑ Bates JE, Amdur RJ, Morris CM, Hitchcock KE, Dziegielewski PT, Boyce BJ, Silver NL, Shaw C, Mendenhall WM (June 2019). "Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database". Am J Clin Oncol 42 (6): 527–533. doi:10.1097/COC.0000000000000550. PMID 31136370.

External links